← Leaderboards
Yongtae Kim
Georgia Institute Of Technology
$3,002,843
Attributed
$3,214,953
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2015–19$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,214,953 · 3
By mechanism
DP2$2,367,000 · 1
R21$847,953 · 2
Top collaborators
- Srikant Rangaraju2 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Pamela Peralta-Yahya$3,213,042
- Mark R Prausnitz$16,440,387
- Andres J Garcia$26,499,681
- Susan Napier Thomas$4,309,850
- Matthew Cribb$108,072
Others in their field
Top investigators on “Nanotechnology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$272,311,477
- David Heimbrook · Leidos Biomedical Research, Inc.$109,987,192
- Roger T Howe · University Of California-Berkeley$94,508,396
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Daniel C Ralph · Cornell University$90,979,534
- Leonard Freedmand · Leidos Biomedical Research, Inc.$64,603,040
Research focus
NanotechnologyMicrofluidicsIn VitroEngineeringCostNanoparticlePharmaceutical PreparationsBaseHigh Density LipoproteinsLeadMouse ModelLibrariesClinical ResearchMolecularCellsBrainAlzheimer&AposInhibitor/AntagonistIn Vitro ModelElectrical ResistanceDrug Delivery SystemsBlood - Brain Barrier AnatomyBiocompatible MaterialsFluorescence Microscopy
Grant awards (5)
Advanced Delivery of Microglial Kv1.3 Channel Blocker for Attenuation of Neuroinflammation of Alzheimer's Disease$185,075
R21 · FY2019 · AG · contact PI
Advanced Delivery of Microglial Kv1.3 Channel Blocker for Attenuation of Neuroinflammation of Alzheimer's Disease$239,146
R21 · FY2018 · AG · contact PI
Probing the functional heterogeneity of high-density lipoprotein using physiological biomimicry$2,367,000
DP2 · FY2017 · HL · contact PI
Targeted delivery of a sonic hedgehog inhibitor for the study of medulloblastoma therapeutics$185,019
R21 · FY2016 · NS · contact PI
Targeted delivery of a sonic hedgehog inhibitor for the study of medulloblastoma therapeutics$238,713
R21 · FY2015 · NS · contact PI